Clinical Trials at Cone Health Cancer Center
As of August 2026, 18 paid clinical trials are recruiting at Cone Health Cancer Center, located at Cone Health Cancer Center at Wesley Long Hospital, 2400 W Friendly Ave, Greensboro, NC 27403, phone (336) 832-1100 in Greensboro, North Carolina. Active studies at this site cover conditions such as Obesity, Overweight and Malignant Solid Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
18 clinical trials at Cone Health Cancer Center
·Clear filters·Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
E-Mindfulness Approaches for Living After Breast Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Common conditions studied in Greensboro
- Obesity (10 active studies)
- Overweight (7 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Heart Failure (4 active studies)
- Breast Cancer (3 active studies)
- Diabetes Mellitus, Type 2 (3 active studies)
Leading research sponsors in Greensboro
- AstraZeneca
- Novo Nordisk A/S
- Eli Lilly and Company
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Greensboro?
There are approximately 107 recruiting clinical trials in Greensboro, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Greensboro pay participants?
Most recruiting trials in Greensboro compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Greensboro?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Greensboro?
The most common conditions under active study in Greensboro include Obesity (10), Overweight (7), Malignant Solid Neoplasm (5), Heart Failure (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Greensboro?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Greensboro on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Greensboro?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Greensboro?
Recruiting research sites in Greensboro include Cone Health Cancer Center, Cone Health Cancer Center at Drawbridge Parkway, Medication Management, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Greensboro right now?
The largest active categories in Greensboro are Cancer & tumors (21), Diabetes & metabolic (16), Cardiovascular (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Cone Health Cancer Center?
Cone Health Cancer Center is located at Cone Health Cancer Center at Wesley Long Hospital, 2400 W Friendly Ave, Greensboro, NC 27403. Use the Google Maps link in the intro above to get directions.
How do I contact Cone Health Cancer Center?
You can reach Cone Health Cancer Center by phone at (336) 832-1100. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.